One randomized controlled trial (RCT) found that exenatide (2 mg weekly for 6 weeks), when combined with a nicotine replacement therapy patch, reduced nicotine cravings, withdrawal symptoms, and post-cessation weight gain, and increased nicotine abstinence compared to placebo or nicotine replacement therapy alone, in individuals who had smoked for at least a year and consumed 10 cigarettes daily [21]
The tirzepatide to semaglutide transition typically involves starting semaglutide at a moderate dose (0.5mg or 1.0mg weekly) rather than the standard 0.25mg starting dose, since the body is already adapted to GLP-1 receptor activation
That pattern can suggest pancreatitis, which is inflammation of the pancreas
Check out heandshecare.com for reviews, expert recommendations, and a curated selection of glutathione face washes
De Vivo DC, Tein I: Primary and secondary disorders of carnitine metabolism